Inhibition of contractions by tricyclic antidepressants and xylamine in rat vas deferens.
The effects of noradrenaline uptake inhibitors on contractions evoked by electric field stimulation, noradrenaline, clonidine. 5-hydroxytryptamine, ATP, high K+, and BaCl2 in the epididymal half of rat isolated vas deferens were examined. Protriptyline, amitriptyline and xylamine concentration-dependently inhibited monophasic contractions induced by low frequency electrical stimulation (0.3 Hz, 1 ms duration, 60 V). Protriptyline and xylamine inhibited in a noncompetitive manner the contractile response induced by noradrenaline (3 x 10(-8)-3 x 10(-5) M) and the inhibitory effect of protriptyline was reversible, while xylamine produced long-lasting inhibition. All three noradrenaline uptake blockers inhibited the clonidine (3 x 10(-6) M) or 5-hydroxytryptamine (10(-5) M)-induced contraction. Protriptyline and amitriptyline at concentrations of 3 x 10(-6)-3 x 10(-5) M reversibly inhibited the ATP (10(-4) M)-induced monophasic contraction. In contrast, xylamine ((1-3) x 10(-5) M) had no effect. Protriptyline and amitriptyline but not xylamine concentration-dependently reduced the high K+ (6 x 10(-2) M)-induced sustained contraction with respective IC50 values of 1.81 x 10(-6) M and 8.6 x 10(-7) M. Protriptyline and amitriptyline at 10(-5) M reversibly inhibited BaCl2 (3 x 10(-3) M)-induced phasic contractions and xylamine (10(-5) M) had no effect. These findings demonstrate that tricyclic antidepressants might exert direct inhibitory action on mechanical contraction pathway, whilst xylamine, a structurally different inhibitor of noradrenaline uptake, may act mainly at alpha-adrenoceptors and other amine receptors on the smooth muscle of the rat vas deferens as a long-lasting nonselective antagonist, and it at least in part blocks sympathetic transmission.
Huang
Y
Y
Department of Physiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, N.T.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D017609:Barium Compounds / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002712:Chlorides / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014649:Vas Deferens / Q000187:drug effects* / Q000502:physiology; D015016:Yohimbine / Q000494:pharmacology
D000929:Antidepressive Agents, Tricyclic; D017609:Barium Compounds; D002712:Chlorides; D009588:Nitrogen Mustard Compounds; C024986:barium chloride; D015016:Yohimbine; C026131:xylamine; D000255:Adenosine Triphosphate; D003000:Clonidine; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine